Bob Ferrigno brings to SynergEyes multi-disciplinary expertise in contact lenses and medical devices, as well as broad business management experience. The SynergEyes, Inc. Board of Directors appointed Bob Ferrigno as Chief Executive Officer, effective June 27, 2018. Ferrigno joined SynergEyes in 2015, bringing a wealth of experience and expertise in the Health Care, Optometry, Medical Device, and Diagnostic Industries.
At SynergEyes he has led the sales and marketing efforts in expanding the company from a hybrid contact lens company to a specialty contact lens company. His team was responsible for launching the SynergEyes VS scleral contact lens, and is currently marketing and selling the new SimplifEyes soft daily contact lens brand.
At SynergEyes Ferrigno has also led the implementation of programs formulated to strengthen services and support for eye care professionals and their patients.
Prior to joining SynergEyes, Ferrigno served as the President of North America for CooperVision (COO). While at CooperVision, he led the integration of the $1.2B Sauflon contact lens company acquisition, focusing on sales infrastructure, logistics, operations and an aggressive launch strategy to rapidly grow contact lens sales in the one-day contact lens segment.
Carolyn M. Maduza
Chief Financial Officer
Carolyn Maduza brings to SynergEyes more than 20 years of successful experience in publicly traded and privately held companies with revenues ranging from start up to $100 million and multi-national in scope. Ms. Maduza will be responsible for growth strategies for SynergEyes, fund raising and capital management, and performance improvement.
Ms. Maduza’s industry expertise includes medical diagnostics, biotech, healthcare IT and enterprise software. Her early career includes systems design, accounting and auditing (CPA), Wall Street corporate banking and investment banking. She has also served as Audit Committee Chair and Financial expert for various Boards of Directors in similar sectors.
Most recently, Ms. Maduza consulted as strategist and interim Chief Financial Officer for Biomatrica, NanoCellect Biomedical, GenMark Diagnostics, and Helixis.
Prior to consulting, Ms. Maduza served as Chief Operating Officer for Sidney Kimmel Cancer Center, Executive Vice President and Chief Financial Officer for Alteer Corporation and Senior Vice President and Chief Financial Officer for Stratagene.
Ms. Maduza holds a Master of International Management from the American Graduate School of International Management, a B.A., Business Administration, from the University of Wisconsin, Milwaukee and a Certified Public Accountant, State of Illinois.